Scinus Group

Scinus Group is a Dutch startup that develops and distributes advanced bioreactor technology for the cultivation of stem cells. Their flagship product, the Osilaris cell expansion platform, is a closed, automated, and GMP-compliant system designed to address the manufacturing challenges in cell therapies. The platform enables dynamic cell expansion, gentle processing with proprietary oxygenation and mixing, and minimizes contamination risks. Scinus aims to make cell therapies more accessible by providing scalable and cost-effective manufacturing solutions for point-of-care production of autologous, clinical-grade cell therapies. They cater to academic ATMP manufacturers and ATMP CDMOs, supporting a range of applications including CAR T-cell therapies, TILs, MSCs, iPSCs, organoids, viral vector production, and extracellular vesicles.